APO Research

APO RESEARCH · REPORT

Hemodialysis and Peritoneal Dialysis

Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure.

Product & engineering

Understand the product.

Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure.

Selected research

Market Outlook & Growth Opportunities

Global Hemodialysis and Peritoneal Dialysis Market Outlook and Growth Opportunities 2026

Market perspective

Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure.

The classification of Hemodialysis and Peritoneal Dialysis includes Service, Device and Consumables, and the proportion of Service in 2019 is about 81.39%.

Hemodialysis and Peritoneal Dialysis sold through in Hospital, Dialysis Center and other. The most of Hemodialysis and Peritoneal Dialysis sold through Dialysis Center, and the market share of that is about 65.29% in 2019.

Read the full market overview

Market competition is intense. Fresenius, DaVita, Baxter, US rental care, B.Braun, Diaverum, etc. are the leaders of the industry.

Production areas mainly include North America, Europe, China and Japan.

North America is the largest consumption place, with a consumption market share nearly 35.08% in 2019. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 28.67% in 2019.

This report provides an overview of the global Hemodialysis and Peritoneal Dialysis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemodialysis and Peritoneal Dialysis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemodialysis and Peritoneal Dialysis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Hemodialysis and Peritoneal Dialysis market.

Hemodialysis and Peritoneal Dialysis Segment by Company

Fresenius

DaVita

Baxter

US rental care

B.Braun

Diaverum

Nipro

Asahi Kasei

Nikkiso

Toray

WEGO

JMS

Medtronic

Rockwell Medical

SWS Hemodialysis Care

Hemodialysis and Peritoneal Dialysis Segment by Type

Service

Device

Consumables

Hemodialysis and Peritoneal Dialysis Segment by Application

Hospital

Dialysis Centers

Other

Hemodialysis and Peritoneal Dialysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hemodialysis and Peritoneal Dialysis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Hemodialysis and Peritoneal Dialysis key companies, revenue, market share, and recent developments.

3. To split the Hemodialysis and Peritoneal Dialysis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Hemodialysis and Peritoneal Dialysis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hemodialysis and Peritoneal Dialysis significant trends, drivers, influence factors in global and regions.

6. To analyze Hemodialysis and Peritoneal Dialysis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemodialysis and Peritoneal Dialysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemodialysis and Peritoneal Dialysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemodialysis and Peritoneal Dialysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hemodialysis and Peritoneal Dialysis industry.

Chapter 3: Detailed analysis of Hemodialysis and Peritoneal Dialysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Hemodialysis and Peritoneal Dialysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Hemodialysis and Peritoneal Dialysis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hemodialysis and Peritoneal Dialysis Industry Trends Table 2. Hemodialysis and Peritoneal Dialysis Industry Drivers Table 3. Hemodialysis and Peritoneal Dialysis Industry Opportunities and Challenges Table 4. Hemodialysis and Peritoneal Dialysis Industry Restraints Table 5. Global Hemodialysis and Peritoneal Dialysis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hemodialysis and Peritoneal Dialysis Revenue Share by Company (2021-2026) Table 7. Global Hemodialysis and Peritoneal Dialysis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Hemodialysis and Peritoneal Dialysis Key Company Manufacturing Base & Headquarters Table 9. Global Hemodialysis and Peritoneal Dialysis Company, Product Type & Application Table 10. Global Hemodialysis and Peritoneal Dialysis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Hemodialysis and Peritoneal Dialysis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Service Table 15. Significant Companies of Device Table 16. Significant Companies of Consumables Table 17. Global Hemodialysis and Peritoneal Dialysis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Hemodialysis and Peritoneal Dialysis Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Hemodialysis and Peritoneal Dialysis Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Type (2021-2026) Table 21. Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Dialysis Centers Table 24. Significant Companies of Other Table 25. Global Hemodialysis and Peritoneal Dialysis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Hemodialysis and Peritoneal Dialysis Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Hemodialysis and Peritoneal Dialysis Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Application (2021-2026) Table 29. Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Application (2027-2032) Table 30. Global Hemodialysis and Peritoneal Dialysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Hemodialysis and Peritoneal Dialysis Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Region (2021-2026) Table 33. Global Hemodialysis and Peritoneal Dialysis Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Region (2027-2032) Table 35. Global Hemodialysis and Peritoneal Dialysis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Hemodialysis and Peritoneal Dialysis Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Hemodialysis and Peritoneal Dialysis Sales Value Market Share by Country (2021-2026) Table 38. Global Hemodialysis and Peritoneal Dialysis Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Hemodialysis and Peritoneal Dialysis Sales Value Market Share by Country (2027-2032) Table 40. Fresenius Company Information Table 41. Fresenius Business Overview Table 42. Fresenius Hemodialysis and Peritoneal Dialysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Fresenius Hemodialysis and Peritoneal Dialysis Product Portfolio Table 44. Fresenius Recent Development Table 45. DaVita Company Information Table 46. DaVita Business Overview Table 47. DaVita Hemodialysis and Peritoneal Dialysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. DaVita Hemodialysis and Peritoneal Dialysis Product Portfolio Table 49. DaVita Recent Development Table 50. Baxter Company Information Table 51. Baxter Business Overview Table 52. Baxter Hemodialysis and Peritoneal Dialysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Baxter Hemodialysis and Peritoneal Dialysis Product Portfolio Table 54. Baxter Recent Development Table 55. US rental care Company Information Table 56. US rental care Business Overview Table 57. US rental care Hemodialysis and Peritoneal Dialysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. US rental care Hemodialysis and Peritoneal Dialysis Product Portfolio Table 59. US rental care Recent Development Table 60. B.Braun Company Information Table 61. B.Braun Business Overview Table 62. B.Braun Hemodialysis and Peritoneal Dialysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. B.Braun Hemodialysis and Peritoneal Dialysis Product Portfolio Table 64. B.Braun Recent Development Table 65. Diaverum Company Information Table 66. Diaverum Business Overview Table 67. Diaverum Hemodialysis and Peritoneal Dialysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Diaverum Hemodialysis and Peritoneal Dialysis Product Portfolio Table 69. Diaverum Recent Development Table 70. Nipro Company Information Table 71. Nipro Business Overview Table 72. Nipro Hemodialysis and Peritoneal Dialysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Nipro Hemodialysis and Peritoneal Dialysis Product Portfolio Table 74. Nipro Recent Development Table 75. Asahi Kasei Company Information Table 76. Asahi Kasei Business Overview Table 77. Asahi Kasei Hemodialysis and Peritoneal Dialysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Asahi Kasei Hemodialysis and Peritoneal Dialysis Product Portfolio Table 79. Asahi Kasei Recent Development Table 80. Nikkiso Company Information Table 81. Nikkiso Business Overview Table 82. Nikkiso Hemodialysis and Peritoneal Dialysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Nikkiso Hemodialysis and Peritoneal Dialysis Product Portfolio Table 84. Nikkiso Recent Development Table 85. Toray Company Information Table 86. Toray Business Overview Table 87. Toray Hemodialysis and Peritoneal Dialysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Toray Hemodialysis and Peritoneal Dialysis Product Portfolio Table 89. Toray Recent Development Table 90. WEGO Company Information Table 91. WEGO Business Overview Table 92. WEGO Hemodialysis and Peritoneal Dialysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. WEGO Hemodialysis and Peritoneal Dialysis Product Portfolio Table 94. WEGO Recent Development Table 95. JMS Company Information Table 96. JMS Business Overview Table 97. JMS Hemodialysis and Peritoneal Dialysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. JMS Hemodialysis and Peritoneal Dialysis Product Portfolio Table 99. JMS Recent Development Table 100. Medtronic Company Information Table 101. Medtronic Business Overview Table 102. Medtronic Hemodialysis and Peritoneal Dialysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Medtronic Hemodialysis and Peritoneal Dialysis Product Portfolio Table 104. Medtronic Recent Development Table 105. Rockwell Medical Company Information Table 106. Rockwell Medical Business Overview Table 107. Rockwell Medical Hemodialysis and Peritoneal Dialysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Rockwell Medical Hemodialysis and Peritoneal Dialysis Product Portfolio Table 109. Rockwell Medical Recent Development Table 110. SWS Hemodialysis Care Company Information Table 111. SWS Hemodialysis Care Business Overview Table 112. SWS Hemodialysis Care Hemodialysis and Peritoneal Dialysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. SWS Hemodialysis Care Hemodialysis and Peritoneal Dialysis Product Portfolio Table 114. SWS Hemodialysis Care Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Hemodialysis and Peritoneal Dialysis Product Image Figure 2. Global Hemodialysis and Peritoneal Dialysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemodialysis and Peritoneal Dialysis Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemodialysis and Peritoneal Dialysis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Service Image Figure 8. Device Image Figure 9. Consumables Image Figure 10. Global Hemodialysis and Peritoneal Dialysis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Hemodialysis and Peritoneal Dialysis Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Dialysis Centers Image Figure 15. Other Image Figure 16. Global Hemodialysis and Peritoneal Dialysis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Hemodialysis and Peritoneal Dialysis Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Application (2021-2032) Figure 19. Global Hemodialysis and Peritoneal Dialysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Hemodialysis and Peritoneal Dialysis Sales Value (2021-2032) & (US$ Million) Figure 22. North America Hemodialysis and Peritoneal Dialysis Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Hemodialysis and Peritoneal Dialysis Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Hemodialysis and Peritoneal Dialysis Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Hemodialysis and Peritoneal Dialysis Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Hemodialysis and Peritoneal Dialysis Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Hemodialysis and Peritoneal Dialysis Sales Value (2021-2032) & (US$ Million) Figure 28. South America Hemodialysis and Peritoneal Dialysis Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Hemodialysis and Peritoneal Dialysis Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Hemodialysis and Peritoneal Dialysis Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Service
  • Device
  • Consumables
Applications
  • Hospital
  • Dialysis Centers
  • Other
Companies covered
  • Fresenius
  • DaVita
  • Baxter
  • US rental care
  • B.Braun
  • Diaverum
  • Nipro
  • Asahi Kasei
  • Nikkiso
  • Toray
  • WEGO
  • JMS
  • Medtronic
  • Rockwell Medical
  • SWS Hemodialysis Care

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemodialysis and Peritoneal Dialysis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemodialysis and Peritoneal Dialysis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Hemodialysis and Peritoneal Dialysis Market Dynamics
  1. 2.1 Hemodialysis and Peritoneal Dialysis Industry Trends
  2. 2.2 Hemodialysis and Peritoneal Dialysis Industry Drivers
  3. 2.3 Hemodialysis and Peritoneal Dialysis Industry Opportunities and Challenges
  4. 2.4 Hemodialysis and Peritoneal Dialysis Industry Restraints
3 Hemodialysis and Peritoneal Dialysis Market by Company
  1. 3.1 Global Hemodialysis and Peritoneal Dialysis Company Revenue Ranking in 2025
  2. 3.2 Global Hemodialysis and Peritoneal Dialysis Revenue by Company (2021-2026)
  3. 3.3 Global Hemodialysis and Peritoneal Dialysis Company Ranking (2024-2026)
  4. 3.4 Global Hemodialysis and Peritoneal Dialysis Company Manufacturing Base and Headquarters
  5. 3.5 Global Hemodialysis and Peritoneal Dialysis Company Product Type and Application
  6. 3.6 Global Hemodialysis and Peritoneal Dialysis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Hemodialysis and Peritoneal Dialysis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Hemodialysis and Peritoneal Dialysis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Hemodialysis and Peritoneal Dialysis Market by Type
  1. 4.1 Hemodialysis and Peritoneal Dialysis Type Introduction
  2. 4.1.1 Service
  3. 4.1.2 Device
  4. 4.1.3 Consumables
  5. 4.2 Global Hemodialysis and Peritoneal Dialysis Sales Value by Type
  6. 4.2.1 Global Hemodialysis and Peritoneal Dialysis Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hemodialysis and Peritoneal Dialysis Sales Value by Type (2021-2032)
  8. 4.2.3 Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Type (2021-2032)
5 Hemodialysis and Peritoneal Dialysis Market by Application
  1. 5.1 Hemodialysis and Peritoneal Dialysis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Dialysis Centers
  4. 5.1.3 Other
  5. 5.2 Global Hemodialysis and Peritoneal Dialysis Sales Value by Application
  6. 5.2.1 Global Hemodialysis and Peritoneal Dialysis Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hemodialysis and Peritoneal Dialysis Sales Value by Application (2021-2032)
  8. 5.2.3 Global Hemodialysis and Peritoneal Dialysis Sales Value Share by Application (2021-2032)
6 Hemodialysis and Peritoneal Dialysis Regional Value Analysis
  1. 6.1 Global Hemodialysis and Peritoneal Dialysis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemodialysis and Peritoneal Dialysis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Hemodialysis and Peritoneal Dialysis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Hemodialysis and Peritoneal Dialysis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemodialysis and Peritoneal Dialysis Sales Value (2021-2032)
  7. 6.3.2 North America Hemodialysis and Peritoneal Dialysis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Hemodialysis and Peritoneal Dialysis Sales Value (2021-2032)
  10. 6.4.2 Europe Hemodialysis and Peritoneal Dialysis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Hemodialysis and Peritoneal Dialysis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Hemodialysis and Peritoneal Dialysis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Hemodialysis and Peritoneal Dialysis Sales Value (2021-2032)
  16. 6.6.2 South America Hemodialysis and Peritoneal Dialysis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Hemodialysis and Peritoneal Dialysis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Hemodialysis and Peritoneal Dialysis Sales Value Share by Country, 2025 VS 2032
7 Hemodialysis and Peritoneal Dialysis Country-level Value Analysis
  1. 7.1 Global Hemodialysis and Peritoneal Dialysis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hemodialysis and Peritoneal Dialysis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Hemodialysis and Peritoneal Dialysis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Hemodialysis and Peritoneal Dialysis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Hemodialysis and Peritoneal Dialysis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Hemodialysis and Peritoneal Dialysis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Hemodialysis and Peritoneal Dialysis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Fresenius
  2. 8.1.1 Fresenius Company Information
  3. 8.1.2 Fresenius Business Overview
  4. 8.1.3 Fresenius Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Fresenius Hemodialysis and Peritoneal Dialysis Product Portfolio
  6. 8.1.5 Fresenius Recent Developments
  7. 8.2 DaVita
  8. 8.2.1 DaVita Company Information
  9. 8.2.2 DaVita Business Overview
  10. 8.2.3 DaVita Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DaVita Hemodialysis and Peritoneal Dialysis Product Portfolio
  12. 8.2.5 DaVita Recent Developments
  13. 8.3 Baxter
  14. 8.3.1 Baxter Company Information
  15. 8.3.2 Baxter Business Overview
  16. 8.3.3 Baxter Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Baxter Hemodialysis and Peritoneal Dialysis Product Portfolio
  18. 8.3.5 Baxter Recent Developments
  19. 8.4 US rental care
  20. 8.4.1 US rental care Company Information
  21. 8.4.2 US rental care Business Overview
  22. 8.4.3 US rental care Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 US rental care Hemodialysis and Peritoneal Dialysis Product Portfolio
  24. 8.4.5 US rental care Recent Developments
  25. 8.5 B.Braun
  26. 8.5.1 B.Braun Company Information
  27. 8.5.2 B.Braun Business Overview
  28. 8.5.3 B.Braun Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 B.Braun Hemodialysis and Peritoneal Dialysis Product Portfolio
  30. 8.5.5 B.Braun Recent Developments
  31. 8.6 Diaverum
  32. 8.6.1 Diaverum Company Information
  33. 8.6.2 Diaverum Business Overview
  34. 8.6.3 Diaverum Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Diaverum Hemodialysis and Peritoneal Dialysis Product Portfolio
  36. 8.6.5 Diaverum Recent Developments
  37. 8.7 Nipro
  38. 8.7.1 Nipro Company Information
  39. 8.7.2 Nipro Business Overview
  40. 8.7.3 Nipro Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nipro Hemodialysis and Peritoneal Dialysis Product Portfolio
  42. 8.7.5 Nipro Recent Developments
  43. 8.8 Asahi Kasei
  44. 8.8.1 Asahi Kasei Company Information
  45. 8.8.2 Asahi Kasei Business Overview
  46. 8.8.3 Asahi Kasei Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Asahi Kasei Hemodialysis and Peritoneal Dialysis Product Portfolio
  48. 8.8.5 Asahi Kasei Recent Developments
  49. 8.9 Nikkiso
  50. 8.9.1 Nikkiso Company Information
  51. 8.9.2 Nikkiso Business Overview
  52. 8.9.3 Nikkiso Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nikkiso Hemodialysis and Peritoneal Dialysis Product Portfolio
  54. 8.9.5 Nikkiso Recent Developments
  55. 8.10 Toray
  56. 8.10.1 Toray Company Information
  57. 8.10.2 Toray Business Overview
  58. 8.10.3 Toray Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Toray Hemodialysis and Peritoneal Dialysis Product Portfolio
  60. 8.10.5 Toray Recent Developments
  61. 8.11 WEGO
  62. 8.11.1 WEGO Company Information
  63. 8.11.2 WEGO Business Overview
  64. 8.11.3 WEGO Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 WEGO Hemodialysis and Peritoneal Dialysis Product Portfolio
  66. 8.11.5 WEGO Recent Developments
  67. 8.12 JMS
  68. 8.12.1 JMS Company Information
  69. 8.12.2 JMS Business Overview
  70. 8.12.3 JMS Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  71. 8.12.4 JMS Hemodialysis and Peritoneal Dialysis Product Portfolio
  72. 8.12.5 JMS Recent Developments
  73. 8.13 Medtronic
  74. 8.13.1 Medtronic Company Information
  75. 8.13.2 Medtronic Business Overview
  76. 8.13.3 Medtronic Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Medtronic Hemodialysis and Peritoneal Dialysis Product Portfolio
  78. 8.13.5 Medtronic Recent Developments
  79. 8.14 Rockwell Medical
  80. 8.14.1 Rockwell Medical Company Information
  81. 8.14.2 Rockwell Medical Business Overview
  82. 8.14.3 Rockwell Medical Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Rockwell Medical Hemodialysis and Peritoneal Dialysis Product Portfolio
  84. 8.14.5 Rockwell Medical Recent Developments
  85. 8.15 SWS Hemodialysis Care
  86. 8.15.1 SWS Hemodialysis Care Company Information
  87. 8.15.2 SWS Hemodialysis Care Business Overview
  88. 8.15.3 SWS Hemodialysis Care Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
  89. 8.15.4 SWS Hemodialysis Care Hemodialysis and Peritoneal Dialysis Product Portfolio
  90. 8.15.5 SWS Hemodialysis Care Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research